TGen News & Press Releases

Single-cell RNA sequencing reveals details about individual cells in pancreatic tumors

Posted Tuesday September 29, 2020

TGen and HonorHealth investigators suggest this granular analysis could lead to better treatments for pancreatic cancer patients

TGen launches Vidium Animal Health

Posted Monday September 28, 2020

TGen subsidiary offers genomic diagnostics in support of veterinary oncologists and pet parents treating canine cancer

September 27th Hope Through Hollis Golf Tournament funds TGen childhood brain cancer research

Posted Monday September 21, 2020

Fundraiser at Papago Golf Course remembers 7-year-old Phoenix boy and his valiant fight against DIPG cancer

NCI funds research into why glioblastoma hits males harder than females

Posted Thursday September 17, 2020

TGen technology is key to brain cancer research consortium led by Cleveland Clinic and Case Western Reserve University

Arizona COVID-19 Genomics Union tracks strains of SARS-CoV-2

Posted Tuesday September 15, 2020

Molecular clock analysis showed no widespread ‘community’ distribution of the highly contagious coronavirus disease in Arizona until mid-February

TGen and Mayo Clinic researchers ID potential targets for the most-deadly form of pancreatic cancer

Posted Monday September 14, 2020

Multi-year study published today tees-up clinical trials using patient-specific therapies

City of Hope, TGen researchers find link between gut microbiome and cancer treatment outcomes

Posted Wednesday August 19, 2020

Study highlights positive impact of microbial diversity on immunotherapy response and suggests that cancer patients should eat a high-fiber diet with fruits, vegetables and grains with resistant starches

TGen review article suggests postmenopausal women at risk for nonalcoholic fatty liver disease

Posted Friday August 14, 2020

Diet, exercise and hormone therapy may potentially benefit postmenopausal women; lack of hormone replacement therapy studies called ‘a critical gap in clinical research’

COMBAT study preliminary results show response of 32% in treatment of pancreatic tumors